Marc Semigran Edgewise Therapeutics, Inc. (EWTX) insider trading activity

EWTX Quotes by TradingView

Marc Semigran is Chief Development Officer of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 6,716 shares of EWTX, which is worth approximately $190,062. The most recent transaction as insider was on Dec 24, 2024, when has been sold 29,709 shares (Common Stock) at a price of $29.87 per share, resulting in proceeds of $887,407. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.72K
n/a 3M change
n/a 12M change
Total Value Held $190,062

Marc Semigran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 24 2024
SELL
Open market or private sale
$887,407 $29.87 p/Share
29,709 Reduced 81.56%
6,716 Common Stock
Dec 24 2024
BUY
Exercise of conversion of derivative security
$265,598 $8.94 p/Share
29,709 Added 44.92%
36,425 Common Stock

Also insider at

RCOR
Renovacor, Inc. Healthcare
Chief Medical Officer
MS

Marc Semigran

Chief Development Officer
Greenwich, CT

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EWTX